Gyre Therapeutics (GYRE) Total Debt (QoQ) (2011 - 2017)
Powered by 
Analysis
Gyre Therapeutics (GYRE) Total Debt (QoQ) (2011 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -7.34% |
| Sep 30, 2017 | -4.89% |
| Jun 30, 2017 | -54.39% |
| Mar 31, 2017 | -34.80% |
| Dec 31, 2016 | -34.60% |
| Sep 30, 2016 | -2.23% |
| Jun 30, 2016 | -1.91% |
| Mar 31, 2016 | -8.32% |
| Dec 31, 2015 | -2.97% |
| Sep 30, 2014 | -31.62% |
| Jun 30, 2014 | -23.86% |
| Mar 31, 2014 | -19.19% |
| Dec 31, 2013 | -15.91% |
| Sep 30, 2013 | -13.67% |
| Jun 30, 2013 | -11.88% |
| Mar 31, 2013 | -10.62% |
| Dec 31, 2012 | -9.48% |
| Sep 30, 2012 | -9.82% |
| Jun 30, 2012 | -8.91% |
| Mar 31, 2012 | -17.20% |